COMMUNIQUÉS West-GlobeNewswire

-
Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
09/07/2025 -
Dr. Anosh Ahmed Plans $25,000 Donation to Support FBI Families and Law Enforcement Mental Health Programs
09/07/2025 -
Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
09/07/2025 -
The Anosh Foundation Launches Global Oversight Initiative to Strengthen COVID-19 Testing and Vaccination Integrity
09/07/2025 -
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
09/07/2025 -
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025
09/07/2025 -
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
09/07/2025 -
Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
09/07/2025 -
Vireo Growth Inc. Announces Retirement of November 2024 Convertible Note
09/07/2025 -
FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank
09/07/2025 -
THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery
09/07/2025 -
Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network
09/07/2025 -
Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies
09/07/2025 -
Ernexa Therapeutics Regains Compliance with Nasdaq Listing Requirements
09/07/2025 -
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
09/07/2025 -
Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
09/07/2025 -
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
09/07/2025 -
Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045
09/07/2025 -
Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines
09/07/2025
Pages